RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS

Clinical trials for RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS explained in plain language.

Never miss a new study

Get alerted when new RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS trials appear

Sign up with your email to follow new studies for RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Scientists track patients years after pioneering HIV gene treatment

Disease control Ongoing

This study is checking for any long-term safety problems in people who previously received an experimental gene therapy for HIV. The therapy involved modifying a person's own blood cells to help them fight the virus. Researchers are following 11 participants to see if any delayed…

Matched conditions: RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS

Sponsor: Calimmune, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS

Get alerted when new RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS trials appear

Scientists track patients years after pioneering HIV gene treatment